Discipline of Obstetrics and Gynaecology, School of Paediatrics and Reproductive Health, The University of Adelaide, Women's and Children's Hospital, 72 King William Road, North Adelaide, SA 5006, Australia.
Best Pract Res Clin Obstet Gynaecol. 2009 Dec;23(6):795-807. doi: 10.1016/j.bpobgyn.2009.06.004. Epub 2009 Jul 16.
Foetal growth restriction is an important and often under-diagnosed complication of pregnancy with important implications for maternal, infant, child and later health. The key to prevention of foetal growth restriction is the recognition of those women at risk and implementation of effective interventions. Ideally, all women should plan pregnancy, providing an opportunity for lifestyle change, reduction of risk factors and optimisation of medical conditions. Failing adequate preconception care, antenatal care should include an assessment of risk factors in early pregnancy, so appropriate interventions may be instituted. Effective interventions are available for women with HIV and also those living in malaria-endemic areas. Antiplatelet agents reduce the risk of pre-eclampsia and small-for-gestational age (SGA) babies in women at risk. Intrauterine treatments offer limited benefit to the baby with foetal growth restriction. The key to management is likely to be optimising the conditions of delivery and minimising neonatal morbidity as much as possible.
胎儿生长受限是妊娠的一种重要且常被低估的并发症,对母婴、儿童和以后的健康都有重要影响。预防胎儿生长受限的关键是识别有风险的妇女,并实施有效的干预措施。理想情况下,所有妇女都应计划怀孕,有机会改变生活方式,减少危险因素,并优化医疗条件。如果没有足够的孕前保健,产前保健应在早孕时评估危险因素,以便进行适当的干预。对于感染 HIV 的妇女和生活在疟疾流行地区的妇女,有有效的干预措施。抗血小板药物可降低有风险的妇女发生子痫前期和胎儿生长受限(SGA)婴儿的风险。宫内治疗对胎儿生长受限的婴儿益处有限。管理的关键可能是尽量优化分娩条件,最大限度地减少新生儿发病率。